A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
This is a study to evaluate the safety and effectiveness of ADX-N05 compared to placebo in
the treatment of excessive daytime sleepiness in adults with narcolepsy.